Davis Todd C bought LGND
March 25, 2024 · Form 4 insider transaction
Davis Todd C bought 2,156 shares of Ligand Pharmaceuticals Incorporated at $68.51 per share, a transaction worth $147.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,156
Price
$68.51
Total value
$147.7K
InsiderDavis Todd C
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 25, 2024
Filing dateMarch 27, 2024
Shares owned after116,604
OwnershipDirect
10b5-1 planNo
AmendedNo